Qiming U.S. Ventures Management, LLC 13F Holdings · last filed Q3 2025
Qiming U.S. Ventures Management, LLC reported 4 securities worth $55.64M in its SEC 13F filing for Q3 2025 (period ended 2025-09-30). Top holdings: TRML (63.76%), KRRO (31.68%), JSPR (3.97%). Among its top 25 positions this quarter: 2 exited.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | TRML | TOURMALINE BIO INC | $35.5M | 63.76% | 741,691 | Hold |
| 2 | KRRO | KORRO BIO INC | $17.6M | 31.68% | 368,085 | Hold |
| 3 | JSPR | JASPER THERAPEUTICS INC | $2.2M | 3.97% | 928,964 | Hold |
| 4 | KZR | KEZAR LIFE SCIENCES INC | $323,197 | 0.58% | 82,871 | Hold |
| 5 | HLVX | HILLEVAX INC | $0 | 0.00% | 0 | Exited |
| 6 | VTYX | VENTYX BIOSCIENCES INC | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2025-09-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR